All stock lists
Rani Therapeutics Holdings, Inc. (NASDAQ:RANI)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
0.59-0.02 (-3.12%)
Insider Score
––Not scored
RANI Insider Score
Insiders here have filed 2 Form 4s in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
RANI Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 1.71 M | 1.71 M | 1.46 M | 0.00 | 0.00 | 172.00 K |
| Revenue Growth (YoY) | — | 893.02 % | 42.12 % | — | — | — |
| Cost of Revenue | 0.00 | 161.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 1.71 M | 1.55 M | 1.46 M | 0.00 | 0.00 | 172.00 K |
| SG&A Expense | 5.52 M | 4.89 M | 5.09 M | 4.04 M | 5.00 M | 5.62 M |
| R&D Expense | 5.02 M | 5.16 M | 4.91 M | 3.22 M | 5.50 M | 6.57 M |
| Operating Expenses | 10.54 M | 9.89 M | 10.00 M | 7.26 M | 10.51 M | 12.19 M |
| Operating Income | -8.83 M | -8.34 M | -8.54 M | -7.26 M | -10.51 M | -12.01 M |
| Pretax Income | -8.42 M | -8.02 M | -9.07 M | -7.91 M | -11.22 M | -12.74 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -7.39 M | -7.03 M | -10.30 M | -5.41 M | -6.69 M | -7.26 M |
| EPS (Basic) | -0.04 | -0.04 | -0.07 | -0.12 | -0.18 | -0.22 |
| EPS (Diluted) | -0.04 | -0.04 | -0.07 | -0.12 | -0.18 | -0.22 |
| Shares Outstanding | 187.17 M | 180.00 M | 147.09 M | 36.54 M | 36.54 M | 33.44 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.